AME evidence series 001-the society for translational medicine: Clinical practice guidelines for diagnosis and early identification of sepsis in the hospital

Journal of Thoracic Disease

Volumn 8, Issue 9, 2016, Pages 2654-2665

  Zhang, Zhongheng ^a,b   Smischney, Nathan J ^c   Zhang, Haibo ^d   Van Poucke, Sven ^e   Tsirigotis, Panagiotis ^f   Rello, Jordi ^g   Honore, Patrick M ^h   Kuan, Win Sen ^i,w   Ray, Juliet June ^j   Zhou, Jiancang ^a   Shang, You ^k   Yu, Yuetian ^l   Jung, Christian ^m   Robba, Chiara ⁿ   Taccone, Fabio Silvio ^o   Caironi, Pietro ^p   Grimaldi, David ^o   Hofer, Stefan ^q   Dimopoulos, George ^f   Leone, Marc ^r   Hong, Sang Bum ^s   Bahloul, Mabrouk ^t   Argaud, Laurent ^u   Kim, Won Young ^s   Spapen, Herbert D ^h   Rocco, Jose Rodolfo ^v   more..

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG NORMAL UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e DEPARTMENT OF CARDIOLOGY   (Belgium)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

ⁱ NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^k HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^l SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^m UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

ⁿ ADDENBROOKE S HOSPITAL   (United Kingdom)

^o ERASME HOSPITAL   (Belgium)

^p UNIVERSITY OF MILAN   (Italy)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r AIX MARSEILLE UNIVERSITY   (France)

^s University of Ulsan College of Medicine   (South Korea)

^t HABIB BOURGUIBA HOSPITAL   (Tunisia)

^u EDOUARD HERRIOT HOSPITAL   (France)

^v FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^w NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

Diagnosis; Early identification; Sepsis

Indexed keywords

LACTIC ACID; PROCALCITONIN;

ANTIBIOTIC THERAPY; ARTICLE; AUTOMATED ELECTRONIC SEPSIS ALERT SYSTEM; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EXPOSURE; EARLY DIAGNOSIS; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GRADES OF RECOMMENDATION ASSESSMENT DEVELOPMENT AND EVALUATION FRAMEWORK; HUMAN; INCOME GROUP; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LEUKOCYTE COUNT; LOW INCOME AND MIDDLE INCOME COUNTRY; MEDICAL INFORMATION SYSTEM; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGEN SATURATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREDISPOSITION INFECTION RESPONSE AND ORGAN DYSFUNCTION SYSTEM; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; TREATMENT DURATION;

EID: 84991244889     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2016.08.03     Document Type: Article

References (81)

1. Herrán-Monge R, Muriel-Bombín A, García-García MM, et al. Mortality Reduction and Long-Term Compliance with Surviving Sepsis Campaign: A Nationwide Multicenter Study. Shock 2016;45:598-606.
2. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8.
3. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
4. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
5. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:775-87.
6. Yu H, Chi D, Wang S, et al. Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomised controlled trials. BMJ Open 2016;6:e008330.
7. Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015;372:1629-38.
8. Drewry AM, Hotchkiss RS. Sepsis: Revising definitions of sepsis. Nat Rev Nephrol 2015;11:326-8.
9. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10.
10. Angus DC. Opening the Debate on the New Sepsis Definition Defining Sepsis: A Case of Bounded Rationality and Fuzzy Thinking? Am J Respir Crit Care Med 2016;194:14-5.
11. Simpson SQ. New Sepsis Criteria: A Change We Should Not Make. Chest 2016;149:1117-8.
12. Angus DC, Seymour CW, Coopersmith CM, et al. A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria. Crit Care Med 2016;44:e113-21.
13. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-8.
14. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
15. Liu VX, Morehouse JW, Marelich GP, et al. Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values. Am J Respir Crit Care Med 2016;193:1264-70.
16. Marshall JC, Vincent JL, Fink MP, et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000 Crit Care Med 2003;31:1560-7.
17. Granja C, Póvoa P. PIRO and sepsis stratification: reality or a mirage? Rev Bras Ter Intensiva 2015;27:196-8.
18. Macdonald SP, Arendts G, Fatovich DM, et al. Comparison of PIRO, SOFA, and MEDS scores for predicting mortality in emergency department patients with severe sepsis and septic shock. Acad Emerg Med 2014;21:1257-63.
19. Nguyen HB, Van Ginkel C, Batech M, et al. Comparison of Predisposition, Insult/Infection, Response, and Organ dysfunction, Acute Physiology And Chronic Health Evaluation II, and Mortality in Emergency Department Sepsis in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle. J Crit Care 2012;27:362-9.
20. de Groot B, Lameijer J, de Deckere ER, et al. The prognostic performance of the predisposition, infection, response and organ failure (PIRO) classification in high-risk and low-risk emergency department sepsis populations: comparison with clinical judgement and sepsis category. Emerg Med J 2014;31:292-300.
21. Chen YX, Li CS. Risk stratification and prognostic performance of the predisposition, infection, response, and organ dysfunction (PIRO) scoring system in septic patients in the emergency department: a cohort study. Crit Care 2014;18:R74.
22. Surani S, Varon J. Biomarkers in the early diagnosis of sepsis: the quest continues. Am J Emerg Med 2015;33:1671.
23. Stoppelkamp S, Veseli K, Stang K, et al. Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery. PLoS One 2015;10:e0135527.
24. Mussap M, Puxeddu E, Puddu M, et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 2015;451:65-70.
25. Yang AP, Liu J, Yue LH, et al. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis. Clin Chem Lab Med 2016;54:345-51.
26. Halim B, Özlem T, Melek Ç, et al. Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis. Turk J Med Sci 2015;45:578-86.
27. Arabestani MR, Rastiany S, Kazemi S, et al. Conventional, molecular methods and biomarkers molecules in detection of septicemia. Adv Biomed Res 2015;4:120.
28. Mickiewicz B, Tam P, Jenne CN, et al. Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit. Crit Care 2015;19:11.
29. Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol 2014;10:1349-56.
30. Keep JW, Messmer AS, Sladden R, et al. National early warning score at Emergency Department triage may allow earlier identification of patients with severe sepsis and septic shock: a retrospective observational study. Emerg Med J 2016;33:37-41.
31. Gibot S, Béné MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012;186:65-71.
32. Liu Z, Chen J, Liu Y, et al. A simple bioscore improves diagnostic accuracy of sepsis after surgery. J Surg Res 2016;200:290-7.
33. Mahieu LM, De Muynck AO, De Dooy JJ, et al. Prediction of nosocomial sepsis in neonates by means of a computer-weighted bedside scoring system (NOSEP score). Crit Care Med 2000;28:2026-33.
34. Moore LJ, Jones SL, Kreiner LA, et al. Validation of a screening tool for the early identification of sepsis. J Trauma 2009;66:1539-46; discussion 1546-7.
35. Goerlich CE, Wade CE, McCarthy JJ, et al. Validation of sepsis screening tool using StO2 in emergency department patients. J Surg Res 2014;190:270-5.
36. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25.
37. Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitoninguided therapy in intensive care unit patients with severe sepsis and septic shock-a systematic review and metaanalysis. Crit Care 2013;17:R291.
38. de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016;16:819-27.
39. Mat-Nor MB, Md Ralib A, Abdulah NZ, et al. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. J Crit Care 2016;33:245-51.
40. Anand D, Das S, Bhargava S, et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culturenegative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J Crit Care 2015;30:218.e7-12.
41. Gattas DJ, Cook DJ. Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU. J Crit Care 2003;18:52-8.
42. Annane D, Maxime V, Faller JP, et al. Procalcitonin levels to guide antibiotic therapy in adults with nonmicrobiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open 2013;3.
43. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177:498-505.
44. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463-74.
45. Hochreiter M, Köhler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009;13:R83.
46. Jensen JU, Hein L, Lundgren B, et al. Procalcitoninguided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39:2048-58.
47. Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394:221-6.
48. Svoboda P, Kantorová I, Scheer P, et al. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepatogastroenterology 2007;54:359-63.
49. Shehabi Y, Sterba M, Garrett PM, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 2014;190:1102-10.
50. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222-31.
51. Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 2015;19:251.
52. Sirvent JM, Ferri C, Baró A, et al. Fluid balance in sepsis and septic shock as a determining factor of mortality. Am J Emerg Med 2015;33:186-9.
53. de Oliveira FS, Freitas FG, Ferreira EM, et al. Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 2015;30:97-101.
54. Kelm DJ, Perrin JT, Cartin-Ceba R, et al. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock 2015;43:68-73.
55. Zhang Z, Zhang Z, Xue Y, et al. Prognostic value of B-type natriuretic peptide (BNP) and its potential role in guiding fluid therapy in critically ill septic patients. Scand J Trauma Resusc Emerg Med 2012;20:86.
56. Sadaka F, Juarez M, Naydenov S, et al. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intensive Care Med 2014;29:213-7.
57. Zhang X, Liu D, Liu YN, et al. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a metaanalysis. Crit Care 2015;19:323.
58. Wu J, Hu L, Zhang G, et al. Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis. PLoS One 2015;10:e0133057.
59. Wang X, Li ZY, Zeng L, et al. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care 2015;19:245.
60. Ratzinger F, Schuardt M, Eichbichler K, et al. Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients. PLoS One 2013;8:e82946.
61. Kitanovski L, Jazbec J, Hojker S, et al. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein. Support Care Cancer 2014;22:269-77.
62. Singer AJ, Taylor M, Domingo A, et al. Diagnostic characteristics of a clinical screening tool in combination with measuring bedside lactate level in emergency department patients with suspected sepsis. Acad Emerg Med 2014;21:853-7.
63. Makam AN, Nguyen OK, Auerbach AD. Diagnostic accuracy and effectiveness of automated electronic sepsis alert systems: A systematic review. J Hosp Med 2015;10:396-402.
64. Zhang Z. Big data and clinical research: focusing on the area of critical care medicine in mainland China. Quant Imaging Med Surg 2014;4:426-9.
65. Zhang Z. Big data and clinical research: perspective from a clinician. J Thorac Dis 2014;6:1659-64.
66. Angus DC. Fusing Randomized Trials With Big Data: The Key to Self-learning Health Care Systems? JAMA 2015;314:767-8.
67. Hooper MH, Weavind L, Wheeler AP, et al. Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. Crit Care Med 2012;40:2096-101.
68. Meurer WJ, Smith BL, Losman ED, et al. Real-time identification of serious infection in geriatric patients using clinical information system surveillance. J Am Geriatr Soc 2009;57:40-5.
69. Berger T, Birnbaum A, Bijur P, et al. A Computerized Alert Screening for Severe Sepsis in Emergency Department Patients Increases Lactate Testing but does not Improve Inpatient Mortality. Appl Clin Inform 2010;1:394-407.
70. McRee L, Thanavaro JL, Moore K, et al. The impact of an electronic medical record surveillance program on outcomes for patients with sepsis. Heart Lung 2014;43:546-9.
71. Nelson JL, Smith BL, Jared JD, et al. Prospective trial of real-time electronic surveillance to expedite early care of severe sepsis. Ann Emerg Med 2011;57:500-4.
72. Umscheid CA, Betesh J, VanZandbergen C, et al. Development, implementation, and impact of an automated early warning and response system for sepsis. J Hosp Med 2015;10:26-31.
73. Nguyen SQ, Mwakalindile E, Booth JS, et al. Automated electronic medical record sepsis detection in the emergency department. Peer J 2014;2:e343.
74. Thiel SW, Rosini JM, Shannon W, et al. Early prediction of septic shock in hospitalized patients. J Hosp Med 2010;5:19-25.
75. Sawyer AM, Deal EN, Labelle AJ, et al. Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med 2011;39:469-73.
76. Rello J, Leblebicioglu H, members of ESGCIP. Sepsis and septic shock in low-income and middle-income countries: need for a different paradigm. Int J Infect Dis 2016;48:120-2.
77. Baelani I, Jochberger S, Laimer T, et al. Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 2011;15:R10.
78. Neustein SM. The use of pulse oximetry in patients with poor peripheral perfusion. Acta Anaesthesiol Scand 2009;53:415-6.
79. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:417-32.
80. Chandralekha, Gupta P, Trikha A. The north Indian dengue outbreak 2006: a retrospective analysis of intensive care unit admissions in a tertiary care hospital. Trans R Soc Trop Med Hyg 2008;102:143-7.
81. Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J Pediatr (Rio J) 2007;83:S22-35.